Agilon Health面临集体诉讼, 指控投资者误用2025 - 2026年的虚假金融索赔。 Agilon Health faces a class action lawsuit over allegedly false 2025–2026 financial claims that misled investors.

对Agilon Health Inc. (NYSE: AGL)及其部分官员提起了集体诉讼诉讼,指控他们对该公司从2025年2月26日至2025年8月4日的商业和财务前景作了虚假或误导性的陈述。 A class action lawsuit has been filed against Agilon Health, Inc. (NYSE: AGL) and some of its officers, alleging they made false or misleading statements about the company’s business and financial outlook from February 26, 2025, to August 4, 2025. 尽管知道由于行业的挑战和夸大了减少风险战略的效益,无法做到这一点,但投诉申诉执行官还是发布了过于乐观的2026年指导意见。 The complaint claims executives issued overly optimistic 2026 guidance despite knowing it was unachievable due to industry challenges and exaggerated the benefits of risk-reduction strategies. 在此期间购买了Agilon股票的投资者可以加入该案,申请主要原告地位的截止日期为2026年3月2日。 Investors who bought Agilon stock during that period may join the case, with the deadline to request lead plaintiff status set for March 2, 2026. Bronstein, Gewirtz & Grossman, LLC律师事务所正在根据应急费处理此案。 The law firm Bronstein, Gewirtz & Grossman, LLC is handling the case on a contingency fee basis.